El-ASSAL, M. I., & SAMUEL, D. (2022). OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS. International Journal of Pharmacy and Pharmaceutical Sciences, 14(1), 17–27. https://doi.org/10.22159/ijpps.2022v14i1.43145